Be Ahead With Economy And Policy Updates
New Delhi: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr.
Mumbai: Global pharma major Lupin Limited (Lupin) announced the launch of Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar, Delhi, dedicated to
Mumbai: JB Chemicals & Pharmaceuticals Ltd (“The Company”) announced its financial results for the fourth quarter of FY 26 on Monday. India Business:
Chennai: Caplin Steriles Limited (CSL), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval
Bangalore: OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a leading specialty pharmaceutical CDMO, today announced that its partner Orbicular, along with its
MUMBAI: Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced that SPARC has entered
New Delhi: India’s pharmacy industry is achieving new heights in the US market. India’s leading pharmaceutical company Sun Pharma has proposed 11.75‑billion‑dollar acquisition
Gurugram: Jagsonpal Pharmaceuticals Limited (BSE: 507789, NSE: JAGSNPHARM) today announced the audited financial results for the quarter and year ended March 31, 2026.
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
Ahmedabad: Zydus Lifesciences Limited (“Zydus”), an innovation-led global lifesciences company, announced that it has received permission to conduct two Phase III clinical trials
Newsletter
Shastrartha is the Soul of the Indian Knowledge System: Vijender Gupta
Tata’s Voltas Crosses 1 Million AC Sales in FY 26-27
IREDA Celebrates 12th International Day of Yoga with MNRE and SECI
REC Power Development and Consultancy Extends ₹1.25 Crore CSR Support for Kargil